Dynavax Technologies Corporation (NASDAQ: DVAX) shares tumbled 64.9 percent to $4.07 after the disclosure of a Complete Response Letter (CRL) from the FDA on its Biologics License Application for HEPLISAV-B. The drug candidate is meant...
Is a specialty finance company that is involved in commercial real estate assets and to a lesser extent commercial finance assets. The company invests in commercial real estate debt and other commercial finance assets. The company's investment strategy targets commercial real estate assets, commercial finance assets, and residential real estate and related assets.
Commercial real estate assets include:
first mortgage loans
Commercial finance assets include:
senior corporate loans
asset backed securities
private equity investments
The company's residential real estate assets include investments in residential mortgage backed securities (RMBS).
RSO earns money from the spread between revenues from assets less the cost to finance the assets.
RSO is externally managed by Resource Capital Manager, which is a wholly owned subsidiary of Resource America (Nasdaq:REXI), an asset management company involved in financial fund management, real estate, and commercial finance.
As of September 30, 2007
RSO had 75% of its equity capital invested in commercial real estate assets, 24% in commercial bank loans, and 1% in direct financing leases and notes.